Incidence of Adverse Events during Continuous Renal Replacement Therapy
Abbasali Akhoundi(Mayo Clinic), Kianoush Kashani(Mayo Clinic), Myriam Vela(WinnMed), John C. Lieske(Mayo Clinic), Gregory Wilson(The Coordinating Center), Sanjay Chaudhary, Rodrigo Cartin‐Ceba, Myles Monaghan(WinnMed), John Dillon(University of Dundee), Ognjen Gajic, Balwinder Singh(Mayo Clinic)
Cited by 127
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
|Nature Reviews Nephrology|2020|703
Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
|Journal of Alzheimer s Disease|2014|664
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
|JAMA Network Open|2020|644
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548